D05.91
Unspecified type of carcinoma in situ of right breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Carcinoma in situ (CIS) of the right breast is a non-invasive form of breast cancer where abnormal cells are confined within the milk ducts or lobules. The term 'unspecified type' indicates that the specific subtype of the carcinoma has not been identified. This early-stage condition is crucial because, if detected and treated in time, it can prevent the development of invasive breast cancer. Understanding this diagnosis helps women and caregivers make informed decisions about health and treatment options.
Causes & Symptoms
Clinical Causes: Genetic mutations that affect cell growth and division Inherited genetic syndromes such as BRCA1 or BRCA2 gene mutations Hormonal influences, especially prolonged exposure to estrogen Environmental factors including radiation exposure Lifestyle factors like alcohol consumption and obesity
Key Symptoms: Typically asymptomatic, with no noticeable lumps or changes Microcalcifications detected via mammography Possible area of increased tissue density on imaging In some cases, palpable thickening or lump in the breast Changes in nipple appearance or skin of the breast, though less common
Diagnostic & Treatment
Diagnosis Path: The diagnosis of carcinoma in situ of the right breast generally involves several steps:
Treatment Protocols: Treatment strategies for carcinoma in situ of the right breast aim to eliminate abnormal cells and prevent progression. Options include:
Clinical Advice & FAQs
Billing Guidance
Is D05.91 a billable ICD-10 code?
Yes, D05.91 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D05.91?
Clinical documentation must specify the nature of Unspecified type of carcinoma in situ of right breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference